Guidelines On Kaposi’s Sarcoma Treatment: Results From Two Cochrane Systematic Reviews
Background: Kaposi’s sarcoma (KS) is the most frequently observed HIV-associated malignancy in resource-poor settings. Widespread use of antiretroviral therapy (ART) has reduced KS incidence, but KS incidence remains high in countries where HIV is prevalent, and is still associated with poor survival. The World Health Organization (WHO) does not have guidelines for KS treatment. To…